EP1107740A4 - Comprime a liberation lente comprenant du naproxene et de la pseudoephedrine - Google Patents

Comprime a liberation lente comprenant du naproxene et de la pseudoephedrine

Info

Publication number
EP1107740A4
EP1107740A4 EP98941051A EP98941051A EP1107740A4 EP 1107740 A4 EP1107740 A4 EP 1107740A4 EP 98941051 A EP98941051 A EP 98941051A EP 98941051 A EP98941051 A EP 98941051A EP 1107740 A4 EP1107740 A4 EP 1107740A4
Authority
EP
European Patent Office
Prior art keywords
pseudoephedrine
naproxen
release tablet
timed release
timed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP98941051A
Other languages
German (de)
English (en)
Other versions
EP1107740A1 (fr
Inventor
Chris E Platt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority claimed from PCT/US1998/017625 external-priority patent/WO2000010537A1/fr
Publication of EP1107740A1 publication Critical patent/EP1107740A1/fr
Publication of EP1107740A4 publication Critical patent/EP1107740A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
EP98941051A 1998-08-25 1998-08-25 Comprime a liberation lente comprenant du naproxene et de la pseudoephedrine Withdrawn EP1107740A4 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1998/017625 WO2000010537A1 (fr) 1997-03-19 1998-08-25 Comprime a liberation lente comprenant du naproxene et de la pseudoephedrine

Publications (2)

Publication Number Publication Date
EP1107740A1 EP1107740A1 (fr) 2001-06-20
EP1107740A4 true EP1107740A4 (fr) 2002-03-06

Family

ID=22267747

Family Applications (1)

Application Number Title Priority Date Filing Date
EP98941051A Withdrawn EP1107740A4 (fr) 1998-08-25 1998-08-25 Comprime a liberation lente comprenant du naproxene et de la pseudoephedrine

Country Status (5)

Country Link
EP (1) EP1107740A4 (fr)
JP (1) JP2002523358A (fr)
AU (1) AU758880B2 (fr)
CA (1) CA2341485A1 (fr)
MX (1) MXPA01001969A (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1708684A2 (fr) * 2003-09-26 2006-10-11 Alza Corporation Enrobage de medicaments a charge medicamenteuse elevee et procedes de fabrication
PL3515413T3 (pl) * 2016-09-26 2023-11-13 The Procter & Gamble Company Postać dawkowania zapewniająca przedłużoną ulgę
WO2019042995A1 (fr) 2017-08-29 2019-03-07 Conrig Pharma Aps Composition comprenant du tosilate de suplatast

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992004022A1 (fr) * 1990-09-11 1992-03-19 Richardson Vicks Inc. Utilisation de compositions contenant des derives de l'acide 2-(6'-substitue-2'-naphtyle)-acetique pour le traitement de troubles respiratoires
WO1995007103A1 (fr) * 1993-09-07 1995-03-16 The Procter & Gamble Company Compositions contenant un sel d'acide amine d'un agent anti-inflammatoire non steroidien a base d'acide propionique et au moins un decongestionnant ou un expectorant ou un antihistaminique ou un antitussif
US5681582A (en) * 1993-06-14 1997-10-28 Janssen Pharmaceutica N.V. Extended release, film-coated tablet of astemizole and pseudoephedrine
EP0811374A1 (fr) * 1996-05-29 1997-12-10 Pfizer Inc. Formulation d'une combinaison de cetirizine et pseudoephedrine

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5004613A (en) * 1987-07-27 1991-04-02 Mcneil-Ppc, Inc. Oral sustained release pharmaceutical formulation and process
US5073384A (en) * 1989-10-19 1991-12-17 Valentine Enterprises, Inc. Maltodextrin/defoaming composition combinate

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992004022A1 (fr) * 1990-09-11 1992-03-19 Richardson Vicks Inc. Utilisation de compositions contenant des derives de l'acide 2-(6'-substitue-2'-naphtyle)-acetique pour le traitement de troubles respiratoires
US5681582A (en) * 1993-06-14 1997-10-28 Janssen Pharmaceutica N.V. Extended release, film-coated tablet of astemizole and pseudoephedrine
WO1995007103A1 (fr) * 1993-09-07 1995-03-16 The Procter & Gamble Company Compositions contenant un sel d'acide amine d'un agent anti-inflammatoire non steroidien a base d'acide propionique et au moins un decongestionnant ou un expectorant ou un antihistaminique ou un antitussif
EP0811374A1 (fr) * 1996-05-29 1997-12-10 Pfizer Inc. Formulation d'une combinaison de cetirizine et pseudoephedrine

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO0010537A1 *

Also Published As

Publication number Publication date
AU758880B2 (en) 2003-04-03
JP2002523358A (ja) 2002-07-30
AU8919898A (en) 2000-03-14
MXPA01001969A (es) 2002-04-24
CA2341485A1 (fr) 2000-03-02
EP1107740A1 (fr) 2001-06-20

Similar Documents

Publication Publication Date Title
IL128869A0 (en) Pyrozolopyrimidines and pyrazolotriazines
IL141439A0 (en) Immediate release tablet
IL120124A0 (en) Heteroaryl-oxazolidinones their preparation and use
AU9015798A (en) Local oral herbal slow release tablets
EP1070496A4 (fr) Comprimes et procede de fabrication correspondant
HUP9700446A3 (en) Oilsuspension-concentrate and using thereof
GB9806666D0 (en) Antigen preparation and use
GB9702354D0 (en) Compounds and their use
AU132520S (en) Tablet
HUP0100192A3 (en) Improved stomach-action molluscicides and preparation thereof
EP1070497A4 (fr) Comprime et procedes de fabrication de comprime
GB0014374D0 (en) Fluid-gauging systems and methods
GB9725219D0 (en) Tablets
HUP0104723A3 (en) New 2-aminothiazol-fused 2-aminoindans and 2-aminotetralins and their use
EP1107740A4 (fr) Comprime a liberation lente comprenant du naproxene et de la pseudoephedrine
PL328334A1 (en) Preparation and application thereof
EP0998578A4 (fr) Sel-10 et utilisations de sel-10
AU133610S (en) Tablet
IL136514A0 (en) Beta-lipotropin and uses thereof
GB2346316B (en) Food binder and holder
GB9904801D0 (en) Message cube
GB9929581D0 (en) Comjpositions and their use
IL146940A0 (en) Novel calpains and their use
GB2341536B (en) A rack and use thereof
CA80450S (en) Tablet

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20010321

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

A4 Supplementary search report drawn up and despatched

Effective date: 20020117

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

RIC1 Information provided on ipc code assigned before grant

Free format text: 7A 61K 9/22 A, 7A 61K 9/32 B, 7A 61K 9/36 B, 7A 61K 31/137 B, 7A 61K 31/192 B

17Q First examination report despatched

Effective date: 20020704

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20030115